arrow
B

B. Ashleigh Guadagnolo

md anderson cancer center
H指数:46
被引数:6,529

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall – Endorsed by ASTRO

欧洲放射肿瘤学会(ESTRO)关于四肢和躯干壁成人软组织肉瘤放射治疗的临床实践指南——美国放射肿瘤学会(ASTRO)认可

2026-04-160
PRE
Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma

原发性皮肤黑色素瘤术后辅助性低分割放疗后的手术重建毒性

2025-12-090
PRE
Sinonasal Sarcomas Management: An International Consensus Statement

鼻腔鼻窦肉瘤的管理:一项国际共识声明

2025-09-010
OAAI
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

分化型脂肪肉瘤接受免疫检查点阻断治疗:MD Anderson经验

2025-04-300
OA
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1
2024-11-261
OA
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
CANCER
IF5.1
2024-08-273
PRE
Role of bromodomain extra terminal inhibitor (BETi) in combination with radiotherapy for the treatment of NF1-associated malignant peripheral nerve sheath tumor
2024-03-220
PRE
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection
2024-03-010
PRE
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
2024-02-1310
PRE
Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes
2023-11-012
OAAI
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

可切除粘膜黑色素瘤的新辅助检查点抑制剂免疫疗法

2022-10-1730
OAAI